Objective: Millions of children suffer from severe acute malnutrition (SAM) in low-and middle-income countries. Much is known about the effectiveness of community treatment programmes (CMAM) but little is known about postdischarge outcomes after successful treatment. The present study aimed to evaluate post-discharge outcomes of children cured of SAM. Design: Prospective, observational cohort study. Children with SAM who were discharged as cured were followed monthly for 6 months or until they experienced relapse to SAM. 'Cure' was defined as a child achieving a midupper arm circumference (MUAC) of ≥115 mm with ≥15 % weight gain after loss of oedema. Relapse was defined as a child with MUAC < 115 mm and/or oedema at any monthly visit. Setting: Save the Children CMAM programme in Swabi, Pakistan, from January 2012 to December 2014. Subjects: Children aged 6-59 months (n 117) discharged as cured from the CMAM programme were eligible for the study and followed for 6 months. Results: One hundred children (92·6 %) remained free of SAM, eight (7·4 %) relapsed to SAM, nine (8·3 %) were lost to follow-up and none died. Most relapses occurred within 3 months of discharge (mean time to relapse 73·4 (SD 36·2) d). At enrolment, 90 % had moderate acute malnutrition (MAM) and 10 % were not malnourished. By the end of 6 months, 35 % persisted with MAM and the remaining were not malnourished. Conclusions: In rural Pakistan, fewer than 10 % of children cured of SAM relapsed. The first 3 months is the most vulnerable time.
It is estimated that approximately 16 million children under 5 years of age suffer from severe acute malnutrition (SAM) at any given time throughout the world (1) . This estimate is based on results of prevalence surveys. When adjusted to account for incidence, this translates to approximately 110 million cases of SAM occurring each year (2) . The most common approach for treating SAM is the Community-based Management of Acute Malnutrition (CMAM) model. This model includes short-stay inpatient care in stabilization centres and/or outpatient care in outpatient therapeutic programmes that is often delivered at primary health-care centres. The need for an inpatient phase depends on the presence or absence of medical complications such as anorexia, bilateral pitting oedema, lower respiratory tract infection, high fever, severe dehydration, severe anaemia or dulled sensorium (3) (4) (5) . There is considerable literature regarding the effectiveness of CMAM programmes for treating SAM (6) (7) (8) (9) (10) (11) (12) . Less work has been done on what happens to these children after they have been discharged as cured. Some work on post-discharge outcomes of children with SAM from inpatient care has been undertaken (13) and summarized (14) and research has described outcomes of children discharged from outpatient care, although the studies are difficult to compare since discharge criteria and lengths of follow-up varied (15) (16) (17) (18) . Some factors that were identified as associated with relapse during 1-year follow-up included mid-upper arm circumference (MUAC) at discharge below 125 mm, no oil/fat consumption during the past 24 h and incomplete vaccination (18) . There are internationally agreed upon standards for programme effectiveness and coverage of CMAM programmes (19) . There are, however, no such standards for post-discharge relapse and mortality. The absence of useful standards reflects, among many things (such as political will, budgetary issues and lack of awareness of the importance of post-discharge care), the absence of evidence that could be used to formulate such standards. The lack of research on the follow-up of patients discharged as cured from CMAM programmes has been identified as a gap in the literature and a research priority (6, 7, (20) (21) (22) . The CMAM model has been endorsed by the WHO, UNICEF and the World Food Programme (23) , most international non-governmental organizations, most ministries of health and all donors. CMAM includes a component of active case-finding and community mobilization, but most programmes do little work on post-discharge follow-up other than to report the number of readmissions of previous patients who have been discharged as cured or had defaulted from care prior to formal discharge. In 2012, Save the Children conducted a household survey in Khyber Pakhtunkhwa Province (KPK) of Pakistan and found that 4 % of children aged 6-59 months had SAM (MUAC < 115 mm). According to the 2011 National Nutrition Survey in Pakistan, prevalence of SAM had been increasing in KPK (24) . The survey also found that although KPK has relatively low levels of food insecurity compared with other provinces (68·5 % of the sample reported affordability and accessibility of a variety of foods in all seasons compared with a national average of 42·0 %), the diets of only 3 % of children aged 6-23 months met the minimum dietary diversity standard (receiving foods from four or more food groups) and only 52 % met the minimum meal frequency standards (24) . At this time, Save the Children was rolling out its CMAM programme under the Improving Community Health project in Swabi District of KPK, Pakistan. This programme treated children for SAM. No treatment for moderate acute malnutrition (MAM) was offered. There was also no treatment programme for the children discharged as cured from SAM treatment, as is often found in CMAM programmes.
The aim of the present study was to evaluate the postdischarge outcomes of children aged 6-59 months cured of SAM, up to 6 months after discharge from the CMAM programme run by Save the Children in Swabi District of KPK, Pakistan.
Methods
The study design was a prospective, observational cohort study conducted by Save the Children Canada and the Hospital for Sick Children in collaboration with Save the Children Pakistan and Save the Children US.
The study enrolled all eligible children who had been discharged as cured from the outpatient therapeutic programme component of the CMAM programme in Swabi, Topi and Razzar tehsils of Swabi District, Pakistan. Enrolment into the study was ongoing from 1 December 2013 to 29 July 2014. The final follow-up visits for the study were completed in December 2014.
Given that there were no data available on relapse rates in Pakistan and the wide range of relapse rates in the literature, no a priori sample size calculations were done. The sample size was limited to the number of children discharged as cured during the study period.
The CMAM programme was implemented by Save the Children Canada as part of a 3-year collaboration between the Lady Health Workers Program, Department of Health, KPK, Pakistan, Global Affairs Canada and Save the Children, Canada and Pakistan. Lady health workers (LHW) routinely provide preventive care to children and mothers, family planning services, and basic treatment for common illnesses at the village level. Under this collaborative project, community management of SAM was introduced in Pakistan for the first time. Prior to this, the LHW screened children under 5 of years of age for malnutrition and children with SAM were referred to first-level care facilities for further assessment and treatment. In this collaborative project, children identified as having uncomplicated SAM (MUAC < 115 mm) who passed the appetite test (20) and were free of medical complications were referred to the outpatient therapeutic programme run by Save the Children Pakistan and treated using the WHO protocol for CMAM programmes (20) . The appetite test was performed during the home visits by the LHW instructing the mother on how to give the ready-to-eat therapeutic food (RUTF) to the child and assessing whether the child was able to eat an adequate amount of the sachet per weight (25) . Children with bilateral pitting oedema alone or MUAC < 115 mm and the presence of any grade of oedema, as well as those who did not pass the appetite test, had medical complications or whose level of consciousness was diminished, were referred to the inpatient nutrition programme at the district hospital and were eligible for outpatient treatment once complications had resolved. The CMAM programme only treated children with SAM and the discharge criteria were achieving a MUAC ≥ 115 mm and ≥ 15 % weight gain and in the absence of oedema. This followed the WHO guidelines at that time, which recommended the use of percentage weight gain for discharge (26) . Children were given no further nutritional support after discharge.
The participants for the present study were identified and recruited by the LHW. When it was determined that a child had achieved the discharge criteria (i.e. had been discharged as cured) from the CMAM programme, he/she was enrolled into the study. Inclusion criteria were children between 6 and 59 months of age who were discharged as cured from the CMAM programme. Children with congenital anomalies that interfered with their ability to feed by mouth were excluded from the study. Relapse was defined as child with a MUAC < 115 mm and/or oedema at any of the monthly follow-up visits. If the child was identified as having relapsed, he/she was readmitted to the CMAM programme by the LHW.
At enrolment, the LHW obtained informed consent from the caregivers and baseline data were collected. This included a questionnaire to obtain information on demographic and household-level characteristics, household food insecurity based on the Household Food Insecurity Access Scale (HFIAS) (27) , feeding practices and dietary diversity for the child based on Household Dietary Diversity Score (HDDS) (28) . Morbidity data as well as height, weight and MUAC measurements were obtained and the absence of oedema confirmed.
The children were followed monthly by the LHW in their respective catchment areas for a 6-month period or until they experienced relapse to SAM, withdrew from the study or were otherwise lost to follow-up. The caregivers were told to return to the health facility if the child's condition worsened. Field programme assistants provided oversight and supervision throughout the study, including providing relapse verification visits. The monthly followup data included anthropometric measurements (height, weight and MUAC) and oedema, and a questionnaire that included questions on household characteristics, child feeding practices, and any health or dietary-related issues, fever, diarrhoea or vomiting.
Data collection and analysis
The field team consisted of: (i) a study coordinator responsible for overseeing the implementation of the study and for liaising with the Hospital for Sick Children and Save the Children Pakistan; (ii) a field supervisor, responsible for ensuring data quality and supervision of the field programme assistants; and (iii) field programme assistants, responsible for timely and accurate data collection and support and supervision of the LHW, who in turn were responsible for measurements and administration of questionnaires. The field team was trained on the study design and procedures for data collection, including review of anthropometric measurement techniques, identification of oedema and research ethics standards. For each child, at each data collection point, LHW repeated the anthropometric measurements (height, weight, MUAC) three times following the Intergrowth-21st standards (29) . Measurements were taken to the nearest completed unit (i.e. rounded down rather than being rounded up to the nearest unit); MUAC to the nearest 0·1 cm, weight to the nearest 0·1 kg, height/length to the nearest 0·1 cm and age to the nearest month. At the time of data analysis, the mean of three readings of each anthropometric measurement was used.
Data were captured on paper forms by the LHW during the monthly household visits. Completed paper forms were delivered to the field supervisor who reviewed the forms for completeness. Study data were entered and managed using REDCap (Research Electronic Data Capture) tools hosted at the Hospital for Sick Children. REDCap is a secure, web-based application designed to support data capture for research studies (30) . All data entry occurred in Pakistan.
Children were excluded from the study for the following reasons: (i) lost to follow-up (i.e. moved away); (ii) consent withdrawn; and (iii) refusal. There were 182 children admitted into the CMAM programme and 117 children were eligible for enrolment into the study (Fig. 1) .
The relapse rate was calculated as a percentage of children who relapsed to SAM of the 108 children followed in the study.
Statistical analyses were performed using the statistical software package SAS versions 9.3 and 9.4, and graphs were produced using R Language and Environment for Statistical Computing version 3.21 software (31) . Where applicable, means and proportions were compared between relapse and non-relapse cases using t tests and Fisher's exact test, respectively. A Kaplan-Meier survival curve was used to illustrate time to relapse among children who met the relapse criterion (MUAC < 115 mm) during follow-up.
Results
The mean age of the children was 20 (SD 10) months and 42 % were male. (Fig. 2) .
No deaths occurred during the follow-up period. Figure 3 shows the proportions of children having SAM (MUAC < 115 mm or oedema), MAM (MUAC 115-124 mm) or no acute malnutrition (MUAC ≥ 125 mm) at each month of follow-up. There was a progression from MAM to no acute malnutrition throughout the follow-up period. At the start of the study, 90 % had MAM and 10 % did not have malnutrition. By the end of 6 months, 65 % of children showed no malnutrition while 35 % had MAM. Relapse was a relatively rare event. Although there were differences in the characteristics of those who relapsed, the sample size was too small to perform stratified or disaggregated analyses in general or per age group. Diet diversity and child feeding practices at baseline and endline are reported in the online supplementary material, Supplemental Table 1 . The sample size (the number of relapses) is too small for the analysis to have enough power to be meaningful.
Discussion
The present study addressed recovery and relapse of previously malnourished children (with SAM) after discharge from a CMAM programme. Of the children, 7·3 % relapsed within a 6-month period of follow-up while more than 50 % transitioned from a moderate malnutrition state (MAM) to 'not malnourished' while receiving no supplementary nutritional interventions after discharge from the treatment programme.
Other authors have examined relapse rates after treatment for SAM. A follow-up study in Bangladesh in 2012 of SAM children (admission based on weight-for-age Z-score or oedema; discharge based on attaining weight-for-length of 80 % of the National Center for Health Statistics median) showed a 17·8 % relapse rate and 5 % death (15) . The admission and discharge criteria for that study are no *Not including nine subjects who refused to enter the study, withdrew or were lost to follow-up. †Household Food Insecurity Access Scale: 0 = no food insecurity; 27 = severe food insecurity. , moderate acute malnutrition; , relapsed to severe acute malnutrition (SAM)) during 6-month follow-up among children (n 108) aged 6-59 months discharged as cured of SAM from the Save the Children community-based management of acute malnutrition programme in Swabi District of Khyber Pakhtunkhwa Province, Pakistan, January 2012-December 2014 longer used in community programmes and differ from those of other studies, but it does show the vulnerability of children post-discharge from SAM treatment when no supplementary nutritional care is given. The first 3 months showed a high prevalence of illnesses and emphasizes the importance of continued access to health-care facilities for treatment (15) . A CMAM programme in Malawi with 3-month post-discharge follow-up found a 1·9 % relapse rate to SAM (17) . However, there were multiple differences from the current study in the treatment and criteria for discharge in the Malawi study. Discharge was based on MUAC > 125 mm, while in the current study discharge was based on MUAC > 115 mm. In Malawi there was an additional 'proof of cure' week before discharge, the provision of a 2-week supply of RUTF at discharge and 29 % of children were enrolled in a supplementary feeding programme at discharge. The children in Malawi had better nutritional status at discharge than the children in the study reported here. An 18-month post-discharge CMAM study in India of children with SAM described relapse rates of 9·1 % at 3 months and 12·0 % at 6 months (16) . In that study the discharge criterion was MUAC ≥ 120 mm. The relapse rate of 7·4 % found in the current study is in line with the study from India and, like the Indian study, most relapse cases occurred within the first 3 months (six of eight cases). In the Malawi, India and the study reported here, most relapses occurred soon after discharge.
Public Health Nutrition
It is important to note that the Pakistani CMAM programme did not have an associated supplementary feeding programme available for children discharged as cured from the CMAM programme. The degree of household food insecurity, however, was mild in both relapsed and non-relapsed groups (Table 1 ). All the children were discharged as cured. Most were discharged with MAM and thus still vulnerable to the negative effects of acute malnutrition (32) . All children were, however, treated for bacterial and helminthic infections as part of the SAM treatment protocol, received vitamin A, were clinically well and were on a positive growth trajectory. Many emergency programmes continue to treat children until they are cured of MAM or offer some sort of supplementary feeding to support them through the recovery from MAM (32, 33) . Although we did see recovery from MAM in many of our participants (65·0 %, 95 % CI 54·8, 74·3 %) after 6 months, the relapse rates in the present study population are likely to be higher than in a study population in which children continued to be treated until complete recovery from both SAM and MAM, as seen in the study of Binns et al. (17) . Although ours is not a MAM study, the 35 % who remained with MAM were still vulnerable for further nutritional deterioration and one could argue that a 'bridging ration' or supplementary nutrition programme would be helpful post-discharge to ensure that all children reach a state of adequate nutrition, as emphasized in Ethiopia by James et al. (34) . Our study identified that more than half of the relapses occurred within 3 months of discharge from the CMAM programme. Given the small sample size, it was not possible to test for or draw strong conclusions on risk factors, but it seems biologically plausible that children would be most vulnerable to relapse in the first few months after discharge, since this is when many still have MAM and when they are transitioning from a single energy-and micronutrient-dense therapeutic food (RUTF) to a mixed household diet. Research suggests the need to focus on the prevention of associated risk factors beyond the treatment period for SAM, where this is feasible (13) , with an emphasis on the first few months following discharge (35) . Other useful interventions for reducing relapse in CMAM programmes could be implemented either during the programme period or post-discharge; however, this needs to be further explored (36) . Increasing treatment duration by either having a 'proof of cure period' at discharge, where the children need to obtain discharge criteria for two consecutive visits before being eligible for discharge, or by increasing the MUAC discharge threshold are two examples during the programme period (17) . Provision of a take-home ration at discharge or discharge to a supplementary feeding programme could be implemented for the post-discharge period. Follow-up of children post-discharge could be done either by community-based workers for the first 3 months or alternatively by the provision of MUAC tapes to mothers, so they can identify relapse on an ongoing basis (37) . These suggested interventions could apply to all programmes that treat and prevent malnutrition. However, they would likely increase total programme costs unless other components of the programme were changed. RUTF is a major programme cost. It may be possible to reduce the RUTF ration once MUAC meets or exceeds 115 mm to provide similar amounts of nutrients as are provided by MAM treatment programmes (38) . It may also be possible to use less expensive ready-to-use supplementary food products, although this may complicate treatment protocols and programme logistics. There may be more efficient and effective approaches than applying a universal intervention to all children to prevent relapse, which is a fairly rare event. Identified risk factors for relapse could be used to target a subset of children at risk of relapsing to SAM; these children could receive extra treatment prior to discharge or receive a take-home ration and/or post-discharge screening. Identification of risk factors for SAM relapse would require further research using considerably larger sample sizes than the study reported here.
The present study has several limitations. First, the sample size was small due to the constraints of the timeline allotted for the study, number of admissions that occurred and proportion of admissions that were discharged as cured during the study period. The sample size allowed the proportion of children relapsing to SAM to be estimated with useful precision. It was, however, too small to allow factors associated with relapse, including dietary diversity and feeding practices, to be identified. Relapse is a rare event and a much larger study would be required for such an analysis. Second, it should be noted that the present study investigated relapse observed in children admitted into and discharged as cured from the community-based therapeutic care component of a CMAM programme. Children receiving inpatient care were not recruited into the study. Third, the study lacked a control group which would have allowed us to understand better if relapse rates are worse in post-discharge cured SAM cases compared with the cumulative incidence of SAM in a non-SAM/non-MAM cohort. Another limitation is that the study was done using percentage weight gain as one of the discharge criteria. Since criteria for discharge for MUAC-based programmes no longer recommend the use of percentage weight gain, it would be useful to repeat this study with programmes using MUAC alone, which is the discharge criterion currently recommended (20) .
Conclusion
The present study provides additional information on recovery and post-discharge relapse rates for SAM in CMAM programmes in the context of rural Pakistan. The first 3 months are identified as the most vulnerable time for relapse post-discharge. There is a need for further research to identify risk factors for relapse, particularly in the first 3 months after discharge, and for identifying effective interventions to decrease relapse in a variety of different geographic settings.
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